The supply chain for bare wafers is off-kilter. Demand is appreciably higher than the wafer suppliers can keep up with, creating shortages that could...
Paragon 28, Inc. announced today that Albert DaCosta, Chairman and CEO and Steve Deitsch, CFO will be presenting at the Canaccord Genuity Musculoskeletal Conference on March 22nd and 2022 Needham Healthcare Conference on April 11th.
Combination strengthens both companies following impact of pandemic Drives growth and job creation Unlocks exciting opportunities for WestJet and Sunwing employees as part of a vibrant national airline CALGARY, AB and TORONTO, ON, March 2, 2022 /CNW/ – WestJet and Sunwing announced today that they…
CHICAGO & DENVER–(BUSINESS WIRE)–PharmaCann Inc., one of the nation’s largest privately held, vertically integrated cannabis companies, and LivWell Enlightened Health, ... Read More
NEW YORK–(BUSINESS WIRE)–Silver Spike Investment Corp. (NASDAQ: SSIC), a newly-organized closed-end management investment company that has elected to be treated ... Read More
About a year ago, the first psychedelics-focused exchange-traded funds were debited on Toronto's NEO exchange. The ETF, Horizons Psychedelic Stock Index (NEO: PSYK), was launched to focus on the relatively new industry. Less than six months after this launch, Defiance ETF launched the Defiance Next Gen Altered Experience in the U.S. Due to the low-key state of the industry then, both ETFs remained passive and focused on tracking a periodically restructured index. The only active ETF in the U.S. psychedelic sector is the AdvisorShares Psychedelics ETF, launched in September by AdvisorShares.
Australian Bitcoin miner Iris Energy applies for an initial public offering (IPO) on the Nasdaq. The stock code is "IREN". Reportedly, $100 million has been...
NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...
Oct. 15, 2021 02:35 UTC
ENGLEWOOD, Colo.--(BUSINESS WIRE)-- Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot...
The Offering was completed pursuant to an underwriting agreement dated August 19, 2021, entered into among the Company and a syndicate of underwriters...